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The International Atomic Energy Agency has developed a program, named Quality Management
Audits in Nuclear Medicine (QUANUM), to help its Member States to check the status of their
nuclear medicine practices and their adherence to international reference standards, covering all
aspects of nuclear medicine, including quality assurance/quality control of instrumentation,
radiopharmacy (further subdivided into levels 1, 2, and 3, according to complexity of work), ra-
diation safety, clinical applications, as well as managerial aspects. TheQUANUMprogram is based
on both internal and external audits and, with specifically developed Excel spreadsheets, it helps
assess the level of conformance (LoC) to those previously defined quality standards. According
to their level of implementation, the level of conformance to requested standards; 0 (absent) up
to 4 (full conformance). Items scored 0, 1, and 2 are considered non-conformance; items scored
3 and 4 are considered conformance. To assess results of the audit missions performed world-
wide over the last 8 years, a retrospective analysis has been run on reports from a total of 42
audit missions in 39 centers, three of which had been re-audited. The analysis of all audit reports
has shown an overall LoC of 73.9 ± 8.3% (mean ± standard deviation), ranging between 56.6%
and 87.9%. The highest LoC has been found in the area of clinical services (83.7% for imaging
and 87.9% for therapy), whereas the lowest levels have been found for Radiopharmacy Level 2
(56.6%); Computer Systems and Data Handling (66.6%); and Evaluation of the Quality Manage-
ment System (67.6%). Prioritization of non-conformances produced a total of 1687 recommendations
in the final audit report. Depending on the impact on safety and daily clinical activities, they were
further classified as critical (requiring immediate action; n = 276; 16% of the total); major (requir-
ing action in relatively short time, typically from 3 to 6months; n = 604; 36%); whereas the remaining
807 (48%) were classified as minor, that is, to be addressed whenever possible. The greatest pro-
portion of recommendations has been found in the category “Managerial, Organization and
Documentation” (26%); “Staff Radiation Protection and Safety” (17.3%); “Radiopharmaceuticals
Preparation, Dispensing and Handling” (15.8%); and “Quality Assurance/Quality Control” and
“Management of Equipment and Software” (11.4%). The lowest level of recommendations belongs
to the item “Human Resources” (4%). The QUANUM program proved applicable to a wide variety
of institutions, from small practices to larger centers with PET/CT and cyclotrons. Clinical ser-
vices rendered to patients showed a good compliance with international standards, whereas issues
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related to radiation protection of both staff and patients will require a higher degree of attention.
This is a relevant feedback for the International Atomic Energy Agency with regard to the effec-
tive translation of safety recommendations into routine practice. Training on drafting and application
of standard operating procedures should also be considered a priority.
Semin Nucl Med 47:687–693 © 2017 The Authors. Published by Elsevier Inc. This is an open
access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
The International Atomic Energy Agency (IAEA),
1 set up
in 1957 as the world’s center for cooperation in the
nuclear field, works with its Member States and multiple part-
ners worldwide to promote the safe, secure, and peaceful use
of nuclear technologies in various fields, including human
health. For this purpose, among other initiatives, the Divi-
sion of Human Health of the IAEA has developed quality
management programs, which cover the medical fields where
the Division of Human Health2 supports its Member States,
namely radiation oncology, nuclear medicine, and radiology.
With regard to nuclear medicine, the Nuclear Medicine and
Diagnostic Imaging Section, aiming to raise the quality of
nuclear medicine practices in low-middle income countries
up to internationally recognized minimum standards, has de-
veloped a program on Quality Management Audits in Nuclear
Medicine (QUANUM),3 based on a combination of both in-
ternal and external audits. The internal audit processes are
felt as essential to instil a culture of quality in the practice,
followed when requested, by external auditing missions
of multidisciplinary teams fielded by the IAEA through its
Technical Cooperation Program and technically supported by
the Nuclear Medicine and Diagnostic Imaging Section.4,5
Between 2006 and 2007, the QUANUM program was de-
signed as a result of two consultancy meetings involving experts
in clinical nuclear medicine, radiopharmacy, and medical
physics, and initially published in 2008.6 Based on initial feed-
back and experiences, the program was subsequently revised,
and QUANUM v2 was published in 2014.7 The main changes
included the introduction of a more detailed evaluation of
clinical practices; a grading system for a more refined assess-
ment of the level of conformance (LoC); and a specific checklist
for level 3 Radiopharmacy practice, for those centers where
cyclotrons are being operated. For immediate visual repre-
sentation, a graphic tool (radar plot) was also introduced (Fig. 1).
The program sets out a series of comprehensive criteria-
based checklists8 covering 17 thematic areas and focused on
international safety regulations and standards, clinical guide-
lines, and managerial strategies.9-26 Adherence to such criteria
is considered a basic requirement for good patient care in
nuclear medicine while reducing risks (radiation and other
safety issues) inherent to health-care delivery processes.27
In June 2016, the IAEA started an assessment of out-
comes from those missions. The objective was, through the
retrospective analysis of completed QUANUM mission reports,
to review the experience gathered from the audits, and iden-
tify strengths and weaknesses of nuclear medicine practices
Figure 1 Example of a radar plot graphically representing results from one of the audits.
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in emerging economies. This paper reports overall results from
that analysis.
Materials and Methods
This retrospective analysis covered 42 QUANUM audit mis-
sions carried out in 39 centers, from 2008 to 2016. By
geographical area, 6 centers were audited in Central Europe,
11 in Latin America, 19 in Asia, and 2 in Africa (Fig. 2). Three
centers (two in Asia and one in Latin America) had a follow-
up mission. Because in the latter cases only results from the
second audit were considered, and out of the total of 42 mis-
sions one report could not be retrieved, eventually 38 reports
were assessed.
As the original QUANUM program was revised within the
period under investigation, out of the 38 reports, 16 have been
prepared using version 1 of the QUANUM v1 checklists,6 and
the remaining 22 using QUANUM v2.7 Because during the
process of revising the QUANUM program the checklists were
also slightly modified, for the purpose of this analysis, results
from QUANUM v1 checklists have been carefully reorga-
nized to be comparable with data from QUANUM v2.
Depending on the level of adherence to each required stan-
dard, checklists allow the grading of the LoC. Therefore, each
item could be graded as not applicable (eg, when radioim-
munoassay determinations are not carried out in the audited
center); 0 (absent); 1 (planned or approximate); 2 (partially
conform or partially implemented); 3 (largely conform or
largely implemented); or 4 (full conformance). Items scored
0, 1, and 2 are considered non-conformance (NC); items scored
3 and 4 are considered conformance. For each audited center,
the level of adherence to standards (LoC) is assessed as the
percentage of the total score received by the auditors toward
the maximum achievable score, calculated as the number of
applicable questions multiplied by 4, which is the maximum
achievable score for each requirement. The program pro-
vides the score for each individual checklist, as well as the
overall total score.
Almost all checklists were found to be applicable in all
audited institutions, with the exception of the “Tumour and
Hormones” checklists, applicable in only eight centers. Ra-
dionuclide therapy was not applicable in only two centers.
The checklist for the assessment of Radiopharmacy Level 3
was introduced only with the QUANUM v2 spreadsheets and,
because only few centers reached that high level of practice,
data could be collected in only six of the 22 centers audited
with QUANUM v2. Statistical analysis was run using the Mann-
Whitney U test.
Results
Comparison of QUANUM v1 and v2 Checklists
and Analysis of the Levels of Conformance
It was found that the mean LoC from QUANUM v1 was
73.0 ± 25.1% (range: 49.9%-92.0%), whereas the mean scoring
of the QUANUM checklists v2 was 73.6 ± 23.3% (range:
61.6%-87.8%). The Mann-Whitney U test showed no sta-
tistically significant difference (P = 0.26).
After data from QUANUM v1 checklists were reorga-
nized to be comparable with QUANUM v2 data, combined
overall results were assessed. LoCs and level of NC per check-
list, expressed as percentages, are reported in Figure 3.
Figure 2 Geographical distribution of audited centers.
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Overall, audited centers showed a good LoC, 73.4 ± 23.3%
(mean ± 1 standard deviation [SD]), ranging between 56.6%
and 87.9%. We considered a level of 70% or more as good
level of practice.
The checklists on clinical requirements related to diagnos-
tic procedures as well as therapeutic procedures showed
the highest LoC, respectively, as high as 83.7% and 87.9%.
Radiopharmacy level 3 had an average conformance value of
81.9%. On the other hand, Radiopharmacy Level 2 (check-
list #15), Computer Systems and Data Handling (checklist
#8), and Quality Assurance Systems (checklist #7) showed
the lowest values of conformances (56.6%, 66.6%, and 67.6%,
respectively). The standard deviation for each independent
checklist ranged between 10.6% and 34.3%, showing a great
variability among the audited centers. The checklist related
to information technology and computer systems showed the
highest data dispersion.
Prioritization of Non-conformances
The QUANUM methodology requires that auditors, when pre-
paring the final report, prioritize NCs, depending on the impact
they may have on safety and daily practice. They are there-
fore converted into priorities, which are classified as (1) critical,
when they pose a major threat to patients, to staff, or to the
environment itself, and should be addressed immediately;
(2) major, when corrective actions should be implemented
in 3-6 months; and (3) minor, when they could be ad-
dressed in the medium term.
As several NCs observed in different checklists may
have a single root cause, for the purpose of this analysis, the
derived recommendations expressed as critical and major
priorities have been reclassified into nine main topics. For
example, all documentation issues, such as lack of standard
operating procedures (SOPs), were grouped into category 1
(managerial, organization, and documentation), as seen in
Table 1, which is a summary of the nine main topics and their
distribution. Out of a total of 1687 recommendations, 880
(52%) were classified either as critical (276; 16%) or major
(604; 36%) priorities. The average number of critical find-
ings per audit was 7.3 (range 1-25), and of major findings
was 15.9 (range 0-40). It is clear that the number of
nonconformities per site varied significantly.
Evaluation of Clinical Services
The QUANUM v2 checklist allows collecting detailed infor-
mation on specific imaging and therapeutic procedures
from each audited nuclear medicine service (Fig. 4A and 4B).
This is done analyzing up to five cases and their reports,
randomly selected, and assesses them against (1) clinical
information collected at referral; (2) technical procedure;
(3) patient preparation; (4) quality assurance/quality control
(QA/QC) of both radiopharmaceutical and instrumentation;
and (5) reporting and follow-up. The mean scoring esti-
mated from the imaging procedures checklists was 81.0%
(SD ± 22.3%), with a minimum value of 25.5% and a
maximum of 100%. Patient preparation requirements have
Figure 3 Average percentage of conformances and non-conformances per checklist.
Checklist 1: Strategies and policies; Checklist 2: Administration and management; Checklist 3: Human re-
sources development; Checklist 4: Radiation regulations and safety compliance; Checklist 5: Radiation protection
of patients; Checklist 6: evaluation of the quality management system; Checklist 7: Quality control for imaging
equipment; Checklist 8: Computer systems and data handling; Checklist 9: General diagnostic clinical services;
Checklist 12: General radionuclide therapy; Checklist 14: Radiopharmacy operational level 1; Checklist 15:
Radiopharmacy operational level 2; Checklist 16: Radiopharmacy operational level 3; Checklist 17: Hormone
and tumor markers
Note: Checklists 10, 11, and 13, related to clinical practice, do not appear here as they were introduced with
QUANUM v2 and are treated separately.
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been found to have the highest average of conformances
(85.3%), whereas numerous opportunities for improvements
were identified in the area of QA/QC procedures of both in-
strumentation and radiopharmaceutical preparations (76.1%).
As concerns radionuclide therapy, it reached an average of
82.8% (SD ± 22.2%) of conformances, with a minimum value
of 37.5% and a maximum of 100%. Patient preparation also
showed the highest score of the clinical activities, whereas
the reporting and follow-up activities presented the highest
opportunities for improvement.
Discussion
The analysis of QUANUM audit reports has shown interest-
ing aspects related to quality management in nuclear
medicine practices in IAEA Member States. It appears that
the QUANUM program can be applied in a wide variety of
nuclear medicine practices, irrespective of geographical
area and of socioeconomic conditions. There was a great
variability in the size and level of the audited institutions,
from relatively small centers equipped with only one SPECT
system and performing limited diagnostic imaging proce-
dures, to large institutions with SPECT/CT, PET/CT, cyclotron
and radiopharmacy, radioimmunoassay laboratories, and large
radionuclide therapy services.
Prioritization of NCs produced 880 critical and major rec-
ommendations, as well as 807 minor ones. Overall, the highest
percentage (26.0%) of critical and major recommendations
were found in item #1, that is, managerial, organization,
and documentation (Table 1). This is partially owing to the
decision to classify all nonconformities generically because
of inadequate development of quality systems, that is, written
procedures, record-keeping, follow-up of deviations and com-
plaints, training, qualification and validation, SOPs, records
etc., into one single category, namely category #1. SOPs are
in general lacking or, when present, not easily available to
staff, not updated in accordance with international stan-
dards, or not applied in daily routine practice. Procedures are
often carried out based on “word of mouth” instructions. This
clearly does not ensure a standardized practice and contra-
dicts the requirements of a quality management system (QMS).
Checklist 3 (human resources) produced 22.7% of non-
conformities, but only 3.6% of recommendations related
to it (item # 6; Table 1). The high LoC (77.3%) in this cat-
egory, however, is mainly owing to an adequate staffing of
physicians and technologists. However, the structure of the
checklist does not allow fully representing the frequent com-
plaint of understaffing of qualified radiopharmacists and
medical physicists, despite having been reported in 44% and
28% of audited institutions, respectively.
This fact raises a major concern as the consequences of
a lack of qualified personnel in medical physics and
radiopharmacy are reflected by the relatively higher number
of NCs in two related fields.
One of those two fields is “radiation regulation and safety,”
with 19.3% of NCs, as medical physicists are usually respon-
sible for radiation protection. The second area of concern is
related to “radiopharmaceuticals preparation, dispensing, and
handling” (item # 7; Fig. 3). In this field, recommendations
are rated as high as 15.8%, and certainly the absence of a
qualified radiopharmacist has an impact on these activities.
The same considerations apply to the finding that, out of the
73 nonconformities concerning facility design; the majority
were related to radiopharmacy layout and patient waiting areas.
When safety and radiation protection in general are con-
sidered, interesting observations arise when we compare NCs
with recommendations arising from their prioritization (Table 2).
Although the level of NCs recorded by the auditors aver-
aged 25.5% of the requisites of checklist #5 “radiation
protection of the patient,” this produced only 8.9% of the
recommendations (item #3, Fig. 4). This implies that the ob-
served NCs were of minimal impact and probably could be
solved with a simple optimization of the procedures. The same
does not apply to checklist #4 “radiation regulations and safety
compliance” (Fig. 4); here, the level of NCs averages 19.3%,
and the corresponding rate of recommendations was as
high as 17.3% (item #4; Fig. 4), representing in this case the
Table 1 Itemization of the Main Recommendations (Critical and Major) and Their Distribution
Nr Item Critical and
Major Priorities
(%)
1 Managerial, organization, and documentation 229 26.0%
2 Education and training 42 4.8%
3 Patient radiation protection and safety 78 8.9%
4 Staff radiation protection and safety 152 17.3%
5 QA/QC and management of equipment and SW 100 11.4%
6 Human resources 32 3.7%
7 Radiopharmaceutical preparation, dispensing, and handling 139 15.8%
8 Clinical procedures (diagnostic and therapeutic) 35 4.0%
9 Facility design 73 8.3%
Critical (total) 276
Major (total) 604
Overall (total) 880
No. of audits 38
Average no. of critical and major priorities notified per center ~23
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observation of severe deviations from standards and were
flagged as such by the audit team.
If we furthermore consider that recommendations regard-
ing clinical services (item #9; Fig. 4) are 8.3% of the total, it
appears that slightly more than one third of the recommen-
dations are linked to missing or inadequate procedures related
to safety and radiation protection in general (poor area clas-
sification; lack of supervision for staff monitoring or lack of
dosimeters for the extremities; lack of proper monitoring of
workplace contamination, etc.).
As regard radiopharmacy, it should be noted that at op-
erational level 1, all the NCs were related to the lack of SOPs
and the specific training in the field, as well as to a lack of
QA/QC procedures. At operational level 2, the number of NCs
tends to increase, because NCs related to this operational level,
such as lack of specific equipment (eg, laminar airflow cabi-
nets) are added to those of operational level 1, which still apply.
However; when a radiopharmacy reaches operational level 3,
the number of NCs decreases: at this level SOPs, training and
equipment are typically in place, and the number of NCs is
the lowest of all the checklists. This shows that centers with
complex and high-level radiopharmacy activities are ad-
equately funded, and the corresponding equipment and
necessary human resources are generally available.
On the other hand, checklists related to clinical activities,
both diagnostic and therapeutic, showed a high LoC. Al-
though the average percentages of conformances for each of
the 14 general checklists showed a mean value of 73.4 ± 23.3%
(mean ± 1 SD), audits of diagnostic and therapeutic proce-
dures found the highest LoCs and homogeneity, with values
of 83.7% and 87.9%, respectively. It might well be that medical
practitioners, who usually also have managerial responsibili-
ties, tend to focus more on clinical activities, including staffing,
while putting less priority on nonclinical areas, as they are
felt as having a limited impact on patient care. Another pos-
sible explanation could be the reluctance of administrators
to fund additional academic personnel perceived as less
essential.
It might also be that the structure of the audit process of
clinical activities, limited to a few observations and a short
period when everybody is aware of the audit, does not in-
vestigate in sufficient depth. The technique to evaluate this
specific category may have to be reviewed and extended to
include more aspects related to clinical practice. Indeed,
clinical and therapeutic parameters measured in the appro-
priate checklists are relatively basic and restricted to the
formal processes. Purely medical aspects such as the diag-
nostic quality of reports, the relationship with referring
physicians or the role of nuclear medicine representatives in
multidisciplinary conferences are not evaluated, as this kind
of assessments would go far beyond the role and authority
of the auditing team.
Conclusions
For any nuclear medicine service, the adoption of a QMS
should be a strategic decision taken with the aim of
improving the standard of care provided. The design and
implementation of a QMS is influenced by various needs and
Table 2 Translation of NCs Into Critical and Major Priorities and Recommendations
Item % of Non-Conformances % of Recommendations
Checklist 3: Human resources development 22.7% 3.7%
Checklist 4: Radiation regulations and safety compliance 19.3% 17.3%
Checklist 5: Radiation protection of patients 24.6% 8.9%
Figure 4 Radar plots representing the summary of imaging (A) and therapy procedures (B). Red dots represent the average score; yellow dots
the lowest score.
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constraints, particular objectives, the nature of services pro-
vided, the processes employed, and the size and structure
of the nuclear medicine facility. QMSs should be imple-
mented, documented, and duly maintained; effectiveness
should be continuously improved in accordance with the
requirements of professional, regulatory, and accrediting
bodies.
From the experience gathered through the IAEA QUANUM
program, the area of clinical services rendered to patients is
the one with the highest degree of compliance with required
standards, whereas issues related to radiation protection of
both staff and patients require more attention. This should
be considered as important feedback to the IAEA as regard
the effective translation of Basic Safety Standards27 recom-
mendations into routine practice.
More specific training on preparing SOPs should be pro-
vided, and stricter adherence to them should be encouraged
when they are available. If not available, they should be
created to ensure smoother and standardized daily activi-
ties. Implementing a practice of periodical internal audits
and, when needed, follow-up external audits will most likely
also improve radiation protection issues without need for
major investments.
Because of the inherent nature of a self-assessment program,
which is the first step of this audit program, QUANUM should
also result in the introduction of a culture of periodic self-
auditing and continuous improvement.
To assess the outcome of the program, in terms of im-
proved compliance with stated standards, audited centers will
be invited to run a new self-assessment through the Excel tool.
This part of the project is underway and will be reported on
shortly.
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